News

Few Women, Men See Indoor Tanning as Harmful

View on the News

Physicians Again Called On to Counsel Patients

Given the high prevalence of indoor tanning use that was discovered in this study, physicians will once again be called on to counsel patients against a risky behavior, said Dr. Robert P. Dellavalle.

But clinicians – dermatologists no less than primary-care physicians – are already under distinct time pressure and may not have the luxury of devoting several minutes to routine advice against the use of tanning beds. "Primary care clinicians should not reduce the time that they spend counseling teens on seat belt and bicycle helmet use or on tobacco avoidance and cessation [in order] to spend more time on sun safety and tanning bed avoidance," he wrote.

Besides, the efficacy of such advice is questionable. The most recent U.S. Preventive Services Task Force guidelines "found little evidence to determine the effects of counseling on the sun protection behaviors of adults, including avoiding sunlamps and tanning beds, and did not recommend any routine counseling by primary care clinicians to prevent skin cancer," Dr. Dellavalle noted.

"This guideline recommendation is unlikely to change soon as no major (and expensive) randomized controlled trial on skin cancer counseling efficacy appears on the horizon," he wrote.

Dr. Dellavalle is in the department of dermatology at the University of Colorado at Denver, and the Colorado School of Public Health, Aurora. He reported no financial disclosures. These comments were adapted from his editorial accompanying Dr. Choi’s report (Arch. Dermatol. 2010;146:1361-2).


 

FROM THE ARCHIVES OF DERMATOLOGY

The study was supported by the National Cancer Institute. No financial disclosures were reported by the investigators, nor by Dr. Dellavalle.

Pages

Recommended Reading

Sun Exposure Recommendations to Boost Vitamin D Criticized
MDedge Dermatology
Sunscreen Found to Reduce New Primary Melanomas
MDedge Dermatology
Expert Reveals Secrets to Mohs Coding
MDedge Dermatology
Eli Lilly Suspends Phase III Trial of Tasisulam for Melanoma
MDedge Dermatology
New Therapeutic Options in the Medical Management of Advanced Melanoma
MDedge Dermatology
Sentinel Node Biopsy for Melanoma: An Update After Two Decades of Experience
MDedge Dermatology
Office Management of Melanoma Patients
MDedge Dermatology
Dermoscopy of Benign and Malignant Neoplasms in the Pediatric Population
MDedge Dermatology
Pathways to Melanoma
MDedge Dermatology
Epidemiology of Melanoma
MDedge Dermatology